Related Experiment Video

Updated: Aug 11, 2026

Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease

A Flyvbjerg1

  • 1Medical Department M (Diabetes and Endocrinology), Institute of Experimental Clinical Research, University of Aarhus, Aarhus Community Hospital, Denmark.

Diabetologia
|November 18, 2000
PubMed

Insights

Diabetic kidney disease involves complex mechanisms, with growth factors like GH/IGFs, TGF-beta, VEGF, and EGF playing key roles. Targeting these growth factors with antagonists shows promise for renoprotection in diabetic models.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic nephropathy is a major complication of Type I and Type II diabetes, leading to significant morbidity and mortality.
  • The intricate mechanisms driving diabetic kidney disease are not fully understood.
  • Growth factors are implicated as key players in the pathogenesis of diabetic kidney disease.

Purpose of the Study:

  • To review the role of specific growth factors in the development of diabetic kidney disease.
  • To explore how understanding these growth factors can inform new therapeutic strategies.
  • To highlight the potential of growth factor antagonists for renoprotection.

Main Methods:

  • Review of current literature on growth factors in experimental diabetic kidney disease models.
  • Analysis of the effects of growth hormone (GH)/insulin-like growth factors (IGFs), TGF-beta, VEGF, and EGF.
  • Examination of studies utilizing antagonists of these growth factors.

Main Results:

  • Specific growth factors, including GH/IGFs, TGF-beta, VEGF, and EGF, significantly impact experimental diabetic kidney disease.
  • These growth factors are involved in initiating early renal changes in diabetes.
  • Administration of antagonists targeting these growth factors demonstrated renoprotective effects in experimental models.

Conclusions:

  • Enhanced understanding of cellular mechanisms in diabetic kidney disease has led to the development of targeted therapies.
  • Growth factor antagonists represent a promising therapeutic avenue for treating diabetic nephropathy.
  • Targeting specific growth factors offers potential for renoprotection and improved outcomes for diabetic patients.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...